Acrolein increases 5-lipoxygenase expression in murine macrophages through activation of ERK pathway

Toxicology and Applied Pharmacology

Volumn 245, Issue 1, 2010, Pages 76-82

  Kim, Chae E ^b   Lee, Seung J ^b   Seo, Kyo W ^a   Park, Hye M ^a   Yun, Jung W ^a   Bae, Jin U ^a   Bae, Sun S ^a   Kim, Chi D ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

5 Lipoxygenase; Acrolein; EGFR; Macrophages; MAPK

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 6,7 DIMETHYL 2 PHENYLQUINOXALINE; ACROLEIN; ARACHIDONATE 5 LIPOXYGENASE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GELATINASE B; LEUKOTRIENE B4; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CELL LINE; CELL STIMULATION; CELL STRAIN J 774A.1; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ACROLEIN; ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CELL LINE; ENVIRONMENTAL POLLUTANTS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; LEUKOTRIENE B4; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MICE; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR;

MURINAE;

EID: 77952549595     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.02.003     Document Type: Article

References (44)

1. Bhatnagar A. Cardiovascular pathophysiology of environmental pollutants. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H479-H485.
2. Bhatnagar A. Environmental cardiology: studying mechanistic links between pollution and heart disease. Circ. Res. 2006, 99:692-705.
3. Bonomini F., Tengattini S., Fabiano A., Bianchi R., Rezzani R. Atherosclerosis and oxidative stress. Histol. Histopathol. 2008, 23:381-390.
4. Carmella S.G., Chen M., Zhang Y., Zhang S., Hatsukami D.K., Hecht S.S. Quantitation of acrolein-derived (3-hydroxypropyl) mercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: effects of cigarette smoking. Chem. Res. Toxicol. 2007, 20:986-990.
5. Cheng C., Tempel D., van Haperen R., van Damme L., Algür M., Krams R., de Crom R. Activation of MMP8 and MMP13 by angiotensin II correlates to severe intra-plaque hemorrhages and collagen breakdown in atherosclerotic lesions with a vulnerable phenotype. Atherosclerosis 2009, 204:26-33.
6. Cheon H., Woo Y.S., Lee J.Y., Kim H.S., Kim H.J., Cho S., Won N.H., Sohn J. Signaling pathway for 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced TNF-alpha production in differentiated THP-1 human macrophages. Exp. Mol. Med. 2007, 39:524-534.
7. Cipollone F., Mezzetti A., Fazia M.L., Cuccurullo C., Iezzi A., Ucchino S., Spigonardo F., Bucci M., Cuccurullo F., Prescott S.M., Stafforini D.M. Association between 5-lipoxygenase expression and plaque instability in humans. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1665-1670.
8. Conklin D.J., Bhatnagar A., Cowley H.R., Johnson G.H., Wiechmann R.J., Sayre L.M., Trent M.B., Boor P.J. Acrolein generation stimulates hypercontraction in isolated human blood vessels. Toxicol. Appl. Pharmacol. 2006, 217:277-288.
9. Deguchi J.O., Aikawa E., Libby P., Vachon J.R., Inada M., Krane S.M., Whittaker P., Aikawa M. Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation 2005, 112:2708-2715.
10. Demirjian L., Abboud R.T., Li H., Duronio V. Acute effect of cigarette smoke on TNF-alpha release by macrophages mediated through the erk1/2 pathway. Biochim. Biophys. Acta 2006, 1762:592-597.
11. Deshmukh H.S., Shaver C., Case L.M., Dietsch M., Wesselkamper S.C., Hardie W.D., Korfhagen T.R., Corradi M., Nadel J.A., Borchers M.T., Leikauf G.D. Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production. Am. J. Respir. Cell Mol. Biol. 2008, 38:446-454.
12. Dwyer J.H., Allayee H., Dwyer K.M., Fan J., Wu H., Mar R., Lusis AJ., Mehrabian M. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N. Engl. J. Med. 2004, 350:29-37.
13. Gough P.J., Gomez I.G., Wille P.T., Raines E.W. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J. Clin. Invest. 2006, 116:59-69.
14. Hazari M.S., Haykal-Coates N., Winsett D.W., Costa D.L., Farraj A.K. A single exposure to particulate or gaseous air pollution increases the risk of aconitine-induced cardiac arrhythmia in hypertensive rats. Toxicol. Sci. 2009, 112(2):532-542.
15. Helgadottir A., Manolescu A., Thorleifsson G., Gretarsdottir S., Jonsdottir H., Thorsteinsdottir U., Samani N.J., Gudmundsson G., Grant S.F., Thorgeirsson G., Sveinbjornsdottir S., Valdimarsson E.M., Matthiasson S.E., Johannsson H., Gudmundsdottir O., Gurney M.E., Sainz J., Thorhallsdottir M., Andresdottir M., Frigge M.L., Topol E.J., Kong A., Gudnason V., Hakonarson H., Gulcher J.R., Stefansson K. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 2004, 36:233-239.
16. Jaimes E.A., DeMaster E.G., Tian R.X, Raij L. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1031-1036.
17. Johnson J.L. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability. Expert Rev. Cardiovasc. Ther. 2007, 5:265-282.
18. Kehrer J.P., Biswal S.S. The molecular effects of acrolein. Toxicol. Sci. 2000, 57:6-15.
19. Kumagai T., Matsukawa N., Kaneko Y., Kusumi Y., Mitsumata M., Uchida K. A lipid peroxidation-derived inflammatory mediator: identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. J. Biol. Chem. 2004, 279:48389-48396.
20. Lee S.J., Kim C.E., Yun M.R., Seo K.W., Park H.M., Yun J.W., Shin H.K., Bae S.S., Kim C.D. 4-Hydroxynonenal enhances MMP-9 production in murine macrophages via 5-lipoxygenase-mediated activation of ERK and p38 MAPK. Toxicol. Appl. Pharmacol. 2010, 242(2):191-198.
21. Leonarduzzi G., Chiarpotto E., Biasi F., Poli G. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol. Nutr. Food Res. 2005, 49:1044-1049.
22. LoPachin R.M., Geohagen B.C., Gavin T. Synaptosomal toxicity and nucleophilic targets of 4-hydroxy-2-nonenal. Toxicol. Sci. 2009, 107:171-181.
23. LoPachin R.M., Gavin T., Petersen D.R., Barber D.S. Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation. Chem. Res. Toxicol. 2009, 22:1499-1508.
24. Lutgens E., van Suylen R.J., Faber B.C., Gijbels M.J., Eurlings P.M., Bijnens A.P., Cleutjens K.B., Heeneman S., Daemen M.J. Atherosclerotic plaque rupture: local or systemic process. Arterioscler. Thromb. Vasc. Biol. 2003, 23:2123-2130.
25. Madamanchi N.R., Vendrov A., Runge M.S. Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2005, 25:29-38.
26. Misonou Y., Asahi M., Yokoe S., Miyoshi E., Taniguchi N. Acrolein produces nitric oxide through the elevation of intracellular calcium levels to induce apoptosis in human umbilical vein endothelial cells: implications for smoke angiopathy. Nitric Oxide 2006, 14:180-187.
27. Osher E., Weisinger G., Limor R., Tordjman K., Stern N. The 5 lipoxygenase system in the vasculature: emerging role in health and disease. Mol. Cell. Endocrinol. 2006, 252:201-206.
28. O'Toole T.E., Zheng Y.T., Hellmann J., Conklin D.J., Barski O., Bhatnagar A. Acrolein activates matrix metalloproteinases by increasing reactive oxygen species in macrophages. Toxicol. Appl. Pharmacol. 2009, 236:194-201.
29. Park Y.S., Kim J., Misonou Y., Takamiya R., Takahashi M., Freeman M.R., Taniguchi N. Acrolein induces cyclooxygenase-2 and prostaglandin production in human umbilical vein endothelial cells: roles of p38 MAP kinase. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1319-1325.
30. Pell J.P., Haw S.J., Cobbe S.M., Newby D.E., Pell A.C., Oldroyd K.G., Murdoch D.L., Pringle S.D., Dunn F.G., Macintyre P.D., Gilbert T.J., Fischbacher C.M., Borland W. Validity of self-reported smoking status: comparison of patients admitted to hospital with acute coronary syndrome and the general population. Nicotine Tob. Res. 2008, 10:861-866.
31. Pope C.A., Burnett R.T., Thurston G.D., Thun M.J., Calle E.E., Krewski D., Godleski J.J. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 2004, 109:71-77.
32. 4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:8161-8166.
33. Rådmark O., Werz O., Steinhilber D., Samuelsson B. 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem. Sci. 2007, 32:332-341.
34. Roethig H.J., Zedler B.K., Kinser R.D., Feng S., Nelson B.L., Liang Q. Short-term clinical exposure evaluation of a second-generation electrically heated cigarette smoking system. J. Clin. Pharmacol. 2007, 47:518-530.
35. Shao B., O'brien K.D., McDonald T.O., Fu X., Oram J.F., Uchida K., Heinecke J.W. Acrolein modifies apolipoprotein A-I in the human artery wall. Ann. N.Y. Acad. Sci. 2005, 1043:396-403.
36. Spanbroek R., Grabner R., Lotzer K., Hildner M., Urbach A., Ruhling K., Moos M.P., Kaiser B., Cohnert T.U., Wahlers T., Zieske A., Plenz G., Robenek H., Salbach P., Kuhn H., Radmark O., Samuelsson B., Habenicht A.J. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:1238-1243.
37. Takamoto S., Sakura N., Namera A., Yashiki M. Monitoring of urinary acrolein concentration in patients receiving cyclophosphamide and ifosphamide. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004, 806:59-63.
38. Vindis C., Escargueil-Blanc I., Elbaz M., Marcheix B., Grazide M.H., Uchida K., Salvayre R., Nègre-Salvayre A. Desensitization of platelet-derived growth factor receptor-beta by oxidized lipids in vascular cells and atherosclerotic lesions: prevention by aldehyde scavengers. Circ. Res. 2006, 98:785-792.
39. Virmani R., Kolodgie F.D., Burke A.P., Farb A., Schwartz S.M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1262-1275.
40. Werz O. 5-lipoxygenase: cellular biology and molecular pharmacology. Curr. Drug Targets Inflamm. Allergy 2002, 1:23-44.
41. Yang S.R., Chida A.S., Bauter M.R., Shafiq N., Seweryniak K., Maggirwar S.B., Kilty I., Rahman I. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L46-L57.
42. Yun M.R., Im D.S., Lee S.J., Woo J.W., Hong K.W., Bae S.S., Kim C.D. 4-hydroxynonenal contributes to macrophage foam cell formation through increased expression of class A scavenger receptor at the level of translation. Free Radic. Biol. Med. 2008, 45:177-183.
43. Zhao L., Moos M.P., Gräbner R., Pédrono F., Fan J., Kaiser B., John N., Schmidt S., Spanbroek R., Lötzer K., Huang L., Cui J., Rader D.J., Evans J.F., Habenicht A.J., Funk C.D. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat. Med. 2004, 10:966-973.
44. 4 pathway in atherosclerotic lesions of diabetic patients promotes plaque instability. Biochem. Biophys. Res. Commun. 2007, 363:30-36.